Ginkgo bioworks announces date of fourth quarter and full year 2021 results presentation and date for annual meeting of shareholders

Presentation and q&a session scheduled for post-market on monday, march 28, 2022 boston , march 17, 2022 /prnewswire/ -- ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and q&a session reviewing business performance for the fourth quarter and full year ended december 31, 2021, on monday, march 28, 2022, beginning at 4:30 p.m. et. the presentation details and webcast registration link will be available on ginkgo's investor relations website at https://investors.ginkgobioworks.com and a replay will be made available.
DNA Ratings Summary
DNA Quant Ranking